A general overview of Lilly's experimental retatrutide and the interest it is drawing for weight management and metabolic health, built around the latest phase 3 data.
Recap by typeshit. Post by @themiddleeasticons on Instagram.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Researchers at the European dermatology congress found 39% of users reported detached nails versus 9% of controls, plus more hair shedding. They urge awareness, not stopping treatment.
Drugwatch, run by a law firm, reports nearly 250 NAION cases in Pennsylvania federal court. Relkin, co-lead counsel in New Jersey, argues for an eye exam before starting a GLP-1.
Loading…